At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Trading 11-22 09:47:41 EST
6.72
+0.13
+1.97%
High6.72Low6.50Vol46.43K
Open6.64D1 Closing6.59Amplitude3.30%
Mkt Cap374.37MTradable Cap251.98MTotal Shares55.71M
T/O308.15KT/O Rate0.12%Tradable Shares37.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
TIPRANKS  ·  11-20 21:00
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
PR Newswire  ·  11-20 20:56
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
Applied DNA Sciences files to sell 41.64M shares of common stock for holders
TIPRANKS  ·  11-19
Applied DNA Sciences files to sell 41.64M shares of common stock for holders
Ginkgo Bioworks price target lowered to $6 from $7 at BTIG
TIPRANKS  ·  11-15
Ginkgo Bioworks price target lowered to $6 from $7 at BTIG
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations
Simply Wall St.  ·  11-15
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations
Ginkgo Bioworks Holdings Inc reports results for the quarter - Earnings Summary
Reuters  ·  11-13
Ginkgo Bioworks Holdings Inc reports results for the quarter - Earnings Summary
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch
GlobeNewswire  ·  11-13
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch
Ginkgo Bioworks surges 14% as it ups 2024 revenue forecast
seekingalpha  ·  11-13
Ginkgo Bioworks surges 14% as it ups 2024 revenue forecast
Ginkgo Bioworks Holdings GAAP EPS of -$1.08 beats by $2.24, revenue of $89.05M beats by $44.06M
seekingalpha  ·  11-13
Ginkgo Bioworks Holdings GAAP EPS of -$1.08 beats by $2.24, revenue of $89.05M beats by $44.06M
Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate
Benzinga  ·  11-13
Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate
Ginkgo Bioworks Holdings Inc: Reduction in Force Is Estimated to Achieve Over $85 Mln in Annualized Savings by Mid-2025
THOMSON REUTERS  ·  11-13
Ginkgo Bioworks Holdings Inc: Reduction in Force Is Estimated to Achieve Over $85 Mln in Annualized Savings by Mid-2025
Ginkgo Bioworks: Will Substantially Consolidate Overall Real Estate Footprint by Exiting Several Facilities in Cambridge, Ma and Europe by Yr End
THOMSON REUTERS  ·  11-13
Ginkgo Bioworks: Will Substantially Consolidate Overall Real Estate Footprint by Exiting Several Facilities in Cambridge, Ma and Europe by Yr End
Press Release: Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
Dow Jones  ·  11-13
Press Release: Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
Ginkgo Bioworks Advances Collaboration with Merck
MT Newswires Live  ·  11-12
Ginkgo Bioworks Advances Collaboration with Merck
Ginkgo Bioworks completes first milestone in Merck collaboration
seekingalpha  ·  11-12
Ginkgo Bioworks completes first milestone in Merck collaboration
BRIEF-Ginkgo Bioworks Advances Collaboration With Merck To Improve Biologics Manufacturing
Reuters  ·  11-12
BRIEF-Ginkgo Bioworks Advances Collaboration With Merck To Improve Biologics Manufacturing
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
Business Wire  ·  11-11
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
We Think Installed Building Products (NYSE:IBP) Might Have The DNA Of A Multi-Bagger
Simply Wall St.  ·  11-10
We Think Installed Building Products (NYSE:IBP) Might Have The DNA Of A Multi-Bagger
We Think Carlisle Companies (NYSE:CSL) Might Have The DNA Of A Multi-Bagger
Simply Wall St.  ·  11-09
We Think Carlisle Companies (NYSE:CSL) Might Have The DNA Of A Multi-Bagger
Ginkgo Bioworks Holdings Inc expected to post a loss of $2.84 a share - Earnings Preview
Reuters  ·  11-09
Ginkgo Bioworks Holdings Inc expected to post a loss of $2.84 a share - Earnings Preview

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--